ArticleAntonie van Leeuwenhoek2025
Characterisation of probiotic potential and whole genome analysis of lactic acid bacteria isolated from Tetragonula Laeviceps and Heterotrigona Itama bee bread.
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Host-AdaptedMicroorganisms · 2026Article
- Genomic, metabolomic, and functional properties of probiotic lactic acid bacteria isolated from Indonesian stingless bee honey.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Stingless bee bread is a fermented bee pollen product containing beneficial lactic acid bacteria (LAB) with potential probiotic properties. This study aimed to characterise the probiotic potential and perform whole genome analysis of LAB isolated from the bee bread of two Indonesian stingless bee species, Tetragonula laeviceps and Heterotrigona itama. Four LAB isolates (BBAT2, BBST20, BBAH2, and BBAH7) were chosen for their ability to combat harmful bacteria, followed by molecular characterisation based on 16S rRNA gene sequence analysis, and identified as Lacticaseibacillus rhamnosus (BBAT2, BBAH2, and BBAH7) and Fructobacillus fructosus (BBST20). Probiotic properties of these isolates were further characterised by digestive tract simulations. Two selected LAB isolates with the highest viability under acidic conditions (80.96-102.10%), gastric juice (80.56-97.92) and bile salt (69.78-102.0%) were L. rhamnosus BBAH2 and BBAH7 followed whole genome sequence (WGS) analysis using PromethION Oxford Nano Technology (ONT). WGS revealed that Lacticaseibacillus rhamnosus BBAH2 (2,987,481 bp) and BBAH7 (2,987,282 bp) belong to the strain Lacticaseibacillus rhamnosus strain JCM 1136 (2,934,834 bp) with an average nucleotide identity (ANI) and ANI based on BLAST + (ANIb) values of 99.88-99 and 99.97% (> 95%), respectively. Genome mining analysis using antiSMASH version 8 beta 1 revealed two regions of biosynthesis gene clusters (T3PKS and RiPP-like), and BAGEL4 revealed one bacteriocin region (carnocin class). The results demonstrated that LAB isolates from stingless bee bread possess desirable probiotic properties and potential genomic characteristics. These strains provide a foundation for the further exploration of their applications in functional foods and nutraceuticals.
Indexed as
Identifiers
41206820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.